Diabetes drug could help cancer patients make better recovery (SGLT2 inhibitors)

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to research. Many cancer patients go on to develop heart failure—because of the cancer itself and also due to chemotherapy. But a study shows that a type of diabetes medication, called an SGLT2 inhibitor, may help protect the heart during and after cancer treatment. This is the first time that any medication has been shown to be beneficial in reducing heart failure or heart failure hospitalization in cancer patients and survivors. The medication appears to lower the risk of heart failure and unplanned hospital...